Zobrazeno 1 - 10
of 8 052
pro vyhledávání: '"GLOMERULOPATHY"'
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Introduction Glomerular diseases, encompassing primary and secondary forms, pose significant morbidity and mortality risks. Despite their impact, little is known about critically ill patients with primary glomerulopathy admitted to the inten
Externí odkaz:
https://doaj.org/article/22406d385ae145509460dae40bf917ae
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-5 (2024)
Abstract Background Fibronectin glomerulopathy (FNG) is a rare autosomal dominant glomerulopathy that can lead to nephrotic syndrome. Here we report the case of an elderly patient diagnosed with FNG, exhibiting nephrotic-range proteinuria, with a 2-y
Externí odkaz:
https://doaj.org/article/e9b099adc40549f6993ae433504a172f
Autor:
Stephanie M. Skinner, Andrew J. Specht, Victoria Cicchirillo, Stacey Fox‐Alvarez, Autumn N. Harris
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 38, Iss 5, Pp 2633-2641 (2024)
Abstract Background Lymphoma has been implicated as a possible cause of proteinuria in dogs. However, information about the potential importance of proteinuria in dogs with lymphoma is limited. Hypothesis To determine if the presence of proteinuria a
Externí odkaz:
https://doaj.org/article/e3205ff1321043c5ba07700cc326001d
Publikováno v:
Medical Journal of Dr. D.Y. Patil Vidyapeeth, Vol 17, Iss 4, Pp 838-841 (2024)
IgG4-related disease (IgG4-RD) is a clinical entity that involves multiple organs and is characterized by high levels of serum IgG4. We present a case of an elderly male reporting fatigue and weight loss, who after extensive workup, was diagnosed as
Externí odkaz:
https://doaj.org/article/6fbcc1431b924cc2831030a2af4ede61
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Introduction People with Tuberculosis (TB) infection may present with glomerulonephritis (GN). The range of presentations, renal pathologies, and clinical outcomes are uncertain. Whether clinical features that establish if GN etiology is med
Externí odkaz:
https://doaj.org/article/4d734bf6fe42482ab3d5e6b827cfd860
Autor:
Nelly Candela, Nicolas Benichou, Mathilde Lefebvre, Lorraine Gueguen, Paula Vieira-Martins, Carine El Sissy, Hervé Sartelet, Pascale Testevuide, Ronan Delaval, Stanislas Faguer
Publikováno v:
Journal of Translational Autoimmunity, Vol 9, Iss , Pp 100254- (2024)
Objective: To compare the natural history of C3 glomerulopathy (C3G) to acute post-infectious glomerulonephritis (APIGN) in a cohort of patients with a relative homogeneity of environment conditions and genetic background. Methods: We retrospectively
Externí odkaz:
https://doaj.org/article/b3359aaed40943c3bb2be8b773b8ee01
Publikováno v:
Transplant International, Vol 37 (2024)
There have been significant advances in short-term outcomes in renal transplantation. However, longer-term graft survival has improved only minimally. After the first post-transplant year, it has been estimated that chronic allograft damage is respon
Externí odkaz:
https://doaj.org/article/c170dd07154b48b1a79583b04f4f11d9
Autor:
Karin Heidenreich, Deepti Goel, P. S. Priyamvada, Sagar Kulkarni, Vipul Chakurkar, Dinesh Khullar, Ravi Singh, Charan Bale, Peter F. Zipfel
Publikováno v:
Frontiers in Nephrology, Vol 4 (2024)
C3 glomerulopathy (C3G) is an ultra-rare complement-mediated kidney disease caused by to the deregulation of the alternative pathway (AP) of proximal complement. Consequently, all effector loops of the complement are active and can lead to pathologie
Externí odkaz:
https://doaj.org/article/b8df9dbc8a8e4fb69f815ce532d9d682
Autor:
Yael Borovitz, Daniel Landau, Amit Dagan, Hadas Alfandari, Orly Haskin, Shelly Levi, Gilad Hamdani, Daniella Levy Erez, Shimrit Tzvi-Behr, Jenny Weinbrand-Goichberg, Ana Tobar Foigelman, Ruth Rahamimov
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundC3 Glomerulopathy (C3G) is a complement-mediated disease, with predominant C3 deposits, where pathogenic genetic variants in complement system components and circulating autoantibodies result in loss of control of the alternative pathway, h
Externí odkaz:
https://doaj.org/article/3d9a585fb5004c1482979bea2b126c24
Autor:
Junichiro Kato, Hideo Okonogi, Go Kanzaki, Haruki Katsumata, Yasuyuki Nakada, Makoto Sagasaki, Kazumasa Komine, Kenji Ito, Takao Saito, Akira Matsunaga, Koh Tokutou, Kazuho Honda, Nobuo Tsuboi, Takashi Yokoo
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Lipoprotein glomerulopathy (LPG) is a apolipoprotein E (ApoE)-related glomerular disease and has been associated with type III hyperlipidemia. Without appropriate treatment, chronic kidney disease (CKD) caused by LPG progresses, a
Externí odkaz:
https://doaj.org/article/1f69d468a94f4af489262968959543e7